Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine-based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153345 | PMC |
http://dx.doi.org/10.1634/theoncologist.2016-0286 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!